$79.97
0.00%
Nasdaq, Thu, Feb 27 2025
ISIN
US45332Y1091
Symbol
NARI

Inari Medical Inc Stock price

$79.97
+0.35 0.44% 1M
+36.52 84.05% 6M
+28.92 56.65% YTD
+21.70 37.24% 1Y
-8.01 9.10% 3Y
+37.46 88.12% 5Y
+37.46 88.12% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.00 0.00%
ISIN
US45332Y1091
Symbol
NARI
Sector

Key metrics

Market capitalization $4.68b
Enterprise Value $4.60b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 857.44
EV/Sales (TTM) EV/Sales 8.01
P/S ratio (TTM) P/S ratio 8.15
P/B ratio (TTM) P/B ratio 10.75
Revenue growth (TTM) Revenue growth 22.41%
Revenue (TTM) Revenue $574.50m
EBIT (operating result TTM) EBIT $-32.04m
Free Cash Flow (TTM) Free Cash Flow $5.37m
Cash position $111.61m
EPS (TTM) EPS $-1.35
P/E forward negative
P/S forward 7.76
EV/Sales forward 7.63
Short interest 5.36%
Show more

Is Inari Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Inari Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Inari Medical Inc forecast:

1x Buy
25%
3x Hold
75%

Analyst Opinions

4 Analysts have issued a Inari Medical Inc forecast:

Buy
25%
Hold
75%

Financial data from Inari Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
575 575
22% 22%
100%
- Direct Costs 88 88
47% 47%
15%
487 487
19% 19%
85%
- Selling and Administrative Expenses 398 398
22% 22%
69%
- Research and Development Expense 104 104
22% 22%
18%
-15 -15
944% 944%
-3%
- Depreciation and Amortization 17 17
84% 84%
3%
EBIT (Operating Income) EBIT -32 -32
201% 201%
-6%
Net Profit -79 -79
2,737% 2,737%
-14%

In millions USD.

Don't miss a Thing! We will send you all news about Inari Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inari Medical Inc Stock News

Neutral
GlobeNewsWire
9 days ago
Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: NARI), a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. The addition of Inari brings an established peripheral vasc...
Neutral
PRNewsWire
15 days ago
NEW YORK , Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE: KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE: SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions.
Neutral
Business Wire
about 2 months ago
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inari Medical, Inc. (NasdaqGS: NARI) to Stryker (NYSE: SYK). Under the terms of the proposed transaction, shareholders of Inari will receive $80.00 in cash for each share of Inari that they own. KSF is seeking to ...
More Inari Medical Inc News

Company Profile

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Head office United States
CEO Andrew Hykes
Employees 1,300
Founded 2011
Website www.inarimedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today